pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-2860Research ArticleОБЗОРЫREVIEWВнебольничные пневмонии у пожилых. Стратегия и тактика антибактериальной терапииCommunity-acquired pneumonia in elderly patients. Strategy and tactics of antibacterial therapyДворецкийЛ. И.DvoretskyL. I.ММА им. И. М. СеченоваRussian Federation200130122001049197Copyright © Дворецкий Л.И., 20012001Дворецкий Л.И.Dvoretsky L.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/2860
.
.
ReferencesДворецкий Л.И. Пневмонии в пожилом и старческом возрасте. Пульмонология 1997; Прил.: 29—35.Дворецкий Л.И. Пневмонии в пожилом и старческом возрасте. Пульмонология 1997; Прил.: 29—35.Синопальников А.И., Дуганов В.К. Левофлоксацин: ступенчатая терапия внебольничной пневмонии у взрослых. Рус. мед. журн. 2001; 15: 650—655.Синопальников А.И., Дуганов В.К. Левофлоксацин: ступенчатая терапия внебольничной пневмонии у взрослых. Рус. мед. журн. 2001; 15: 650—655.Doern G.V. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am. J. Med. 1995; 99: 3S—7S.Doern G.V. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am. J. Med. 1995; 99: 3S—7S.Drinka P.J., Gauerke C., Voeks S. el al. Pneumoniae in nursing home. J. Gen. Intern. Med. 1994; 9: 650—652.Drinka P.J., Gauerke C., Voeks S. el al. Pneumoniae in nursing home. J. Gen. Intern. Med. 1994; 9: 650—652.File T.M., Sergeti G., Player P. et al. A multicenter randomised study comparing the efficacy and safety of intravenous and or oral levofloxacin versus ceftriaxont and or cefuroxime axetil in treatment of adults with community acquired pneumonia. Antimicrob. Agents Chemother. 1997; 41: 1965—1972.File T.M., Sergeti G., Player P. et al. A multicenter randomised study comparing the efficacy and safety of intravenous and or oral levofloxacin versus ceftriaxont and or cefuroxime axetil in treatment of adults with community acquired pneumonia. Antimicrob. Agents Chemother. 1997; 41: 1965—1972.Fine M.J., Auble Т.Н., Yealy D.M. et al. A prediction rule to identify low-risk patients with community acquired-pneumonia. N. Engl. J. Med. 1997; 336: 243—250.Fine M.J., Auble Т.Н., Yealy D.M. et al. A prediction rule to identify low-risk patients with community acquired-pneumonia. N. Engl. J. Med. 1997; 336: 243—250.Kahn J.B., Wiesinger A., Olson W.Ii. et al. Levofloxacin vs ceftriaxone sodium and erytromycin in the treatment of patients with community-acquired pneumonia at high risk of mortality. In: Abstracts of 7th International symposium on new quinolones. Edinburgh; 2001. 45.Kahn J.B., Wiesinger A., Olson W.Ii. et al. Levofloxacin vs ceftriaxone sodium and erytromycin in the treatment of patients with community-acquired pneumonia at high risk of mortality. In: Abstracts of 7th International symposium on new quinolones. Edinburgh; 2001. 45.Koivula I., Stenn V., Makela P.H. Risk factors for pneumonia in the elderly. Am. J. Med. 1994; 96: 313—320.Koivula I., Stenn V., Makela P.H. Risk factors for pneumonia in the elderly. Am. J. Med. 1994; 96: 313—320.McCue J.D. Antibiotic use in the elderly: Issues and nonissues. Clin. Infect. Dis. 1999; 28 (4): 750—752.McCue J.D. Antibiotic use in the elderly: Issues and nonissues. Clin. Infect. Dis. 1999; 28 (4): 750—752.Meehan T.P., Fine M.J., Krumholz Ii.M. et al. Quality of care process and outcomes in elderly patients with pneumonia. J.A M.A. 1997; 278: 2080.Meehan T.P., Fine M.J., Krumholz Ii.M. et al. Quality of care process and outcomes in elderly patients with pneumonia. J.A M.A. 1997; 278: 2080.Norrby S.P., Petermann W., Willcox P.A. et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand. J. Infect. Dis. 1998; 30: 397—404.Norrby S.P., Petermann W., Willcox P.A. et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand. J. Infect. Dis. 1998; 30: 397—404.Pamires J.A. Switch therapy in adult patients with pneumonia. Clin. Pulm. Med. 1995; 2: 327—333.Pamires J.A. Switch therapy in adult patients with pneumonia. Clin. Pulm. Med. 1995; 2: 327—333.Thornsberry C., Ogilvie P., Kahn J. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in United States in 1996—1997 respiratory season. The Laboratory Investigator Group. Diagn. Microbiol. Infect. Dis. 1997; 29: 249—257.Thornsberry C., Ogilvie P., Kahn J. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in United States in 1996—1997 respiratory season. The Laboratory Investigator Group. Diagn. Microbiol. Infect. Dis. 1997; 29: 249—257.
The authors declare that there are no conflicts of interest present.